The global healthcare sector is currently pivoting toward a "test to treat" model, where rapid identification of viral pathogens is the cornerstone of patient care. As we look toward the next decade, the Influenza Diagnostics Market Revenue is poised for substantial growth, driven by a combination of heightened seasonal flu activity and a revolutionary shift in testing technologies. With a...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek